Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 126
Filter
1.
Journal of Southern Medical University ; (12): 145-152, 2023.
Article in Chinese | WPRIM | ID: wpr-971508

ABSTRACT

OBJECTIVE@#To evaluate the clinical features, laboratory and imaging results, treatment and outcomes of eosinophilic fasciitis (EF) and assess the value of ultrasound in the diagnosis of EF.@*METHODS@#We retrospectively analyzed the clinical data of 45 patients with EF treated in our center from January 1, 2006 to February 28, 2022. The consistency between the diagnoses of EF based on ultrasound and MRI findings was assessed.@*RESULTS@#In the 45 EF patients (male/female ratio 3.5:1), the age of onset ranged from 16 to 64 years with a mean disease course of 22.6 months. The average time from symptom onset to diagnosis was 16 months. The most common possible trigger of the disease was vigorous exercise (10/45), causing symmetrical lesions in the limbs, most commonly in the forearms (86.7%) and lower legs (80%). Clinical features of EF included subcutaneous swelling and induration (95.6%), arthralgia and arthritis (55.6%), groove sign (42.2%), hand joint contractures (42.2%), skin pigmentation (37.8%), and peau d'orange appearance (13.3%). Eosinophilia was found in 31 patients (68.9%). Hypergammaglobulinemia was seen in 23/44 (52.3%) and positive antinuclear antibodies in 9 (20%) of the patients. Twentyone of the patients were treated with high-dose methylprednisolone (≥200 mg daily for 3 to 5 consecutive days), and compared with the patients who did not receive this treatment, these patients more frequently experienced relapse before admission, had more extensive involvement, and had a higher rate of hypergammaglobulinemia without fever, but these differences were not statistically significant. Of the 31 patients (68.9%) with follow-up data (for a median of 3.2 years [range 0.2-15.9]), complete remission was achieved in 12 (38.7%) patients, and the accumulative complete remission rate was 44.1% at 5.5 years. No specific baseline characteristics or immunosuppressants were found to correlate with the treatment response. A total of 26 patients underwent both ultrasound and MRI examination, and the Kappa value of the diagnostic results between ultrasound and MRI was 0.91.@*CONCLUSION@#EF is characterized by symmetrical subcutaneous swelling and induration in the limbs, accompanied by eosinophilia and hypergammaglobulinemia. Glucocorticoid is effective for treating EF. Ultrasound examination can identify thickening of subcutaneous fascia for an early diagnosis of EF.


Subject(s)
Humans , Female , Male , Infant , Child, Preschool , Retrospective Studies , Hypergammaglobulinemia , Eosinophilia , Ultrasonography , Hand , Contracture , Treatment Outcome
2.
Rev. cuba. pediatr ; 93(1): e758, ene.-mar. 2021. tab, fig
Article in Spanish | LILACS, CUMED | ID: biblio-1251754

ABSTRACT

Introducción: El síndrome de hiperIgE es una inmunodeficiencia primaria poco frecuente de etiología desconocida, con afectación multisistémica; causada por mutaciones dominantes del gen que codifica la proteína transductora de señal y activadora de la transcripción, STAT-3, por lo que condiciona un déficit en la generación de las células Th17 a partir de las células T CD4+ y explica la susceptibilidad de estos pacientes a las infecciones por Stafilococus aureus y Cándida albicans. Objetivo: Contribuir al conocimiento de esta inmunodeficiencia para su detección precoz y tratamiento oportuno. Presentación del caso: Se trata de una lactante, con puente nasal amplio, hiperlaxitud, erupción eccematosa desde el período neonatal, infecciones cutáneas, óticas, pulmonares con presencia de neumatoceles y candidiasis mucocutánea. Se detectaron concentraciones elevadas de IgE sérica y eosinofília. Se trató con inmunomoduladores, antihistamínicos, antimicrobianos y vitaminoterapia. Se logró mejoría clínica. Conclusiones: El síndrome de hiperIgE-AD es una inmunodeficiencia primaria poco frecuente caracterizada por altas concentraciones de IgE, eosinofilia, abscesos cutáneos, eccemas, candidiasis mucocutánea crónica e infecciones pulmonares recidivantes, neumatoceles y bronquiectasias; también se presentan alteraciones del tejido conectivo, esquelético y vascular. Se requiere de alto grado de sospecha clínica y es importante la atención precoz de las infecciones, que en general presentan una respuesta tórpida sistémica. Las alternativas terapéuticas están dirigidas a prevenir la sepsis y al control de los síntomas(AU)


Introduction: Hyper IgE syndrome is a rare primary immunodeficiency of unknown etiology, with multi systemic impact; it is caused by dominant mutations of the gene that codifies the protein transducer of signal and activator of transcription (STAT-3), therefore it determines a deficit in the generation of Th17 cells from T CD4+ cells, and explains the sensitivity of these patients to the infections caused by Stafilococus aureus and Candida albicans. Objective: Contribute to the knowledge of this immunodeficiency for its early detection and timely treatment. Case presentation: Newborn with wide nasal bridge, hypermovility, eczematose rash since the neonatal period; cutaneous, ear, and pulmonary infections with presence of neumotoceles and mucocutaneous candidiasis. There were detected high concentrations of seric IgE and eosinophilia. The patient was treated with immunomodulators, antihestamines, antimicrobial drugs and vitaminotherapy. It was achieved a clinical improvement. Conclusions: Hyper IgE syndrome-AD is a rare primary immunodeficiency characterized by high concentrations of IgE, eosinophilia, cutaneous abscesses, eczemas, chronical mucocutaneous candidiasis and recurrent pulmonary infections, neumatoceles and bronchiectasis; it also presents alterations in the connective, skeletal and vascular tissue. It is required a high level of clinical suspicion and it is important the early care of the infections, which generally present a systemic torpid response. The therapeutic alternatives are directed to prevent a sepsis and to control the symptoms(AU)


Subject(s)
Humans , Female , Infant , Candidiasis, Chronic Mucocutaneous , Immunoglobulin E , Knowledge , Hypergammaglobulinemia , Immunologic Factors , Anti-Infective Agents
3.
Rev. Soc. Bras. Clín. Méd ; 18(4): 222-226, DEZ 2020.
Article in Portuguese | LILACS | ID: biblio-1361635

ABSTRACT

O mieloma múltiplo é uma neoplasia progressiva e incurável de células B, caracterizado pela proliferação desregulada e clonal de plasmócitos na medula óssea. A síndrome de hiperviscosidade é uma das complicações relacionadas às gamopatias monoclonais, sendo considerada emergência oncológica. O objetivo deste estudo foi descrever o quadro clínico de um paciente diagnosticado com mieloma múltiplo que apresentou síndrome de hiperviscosidade, avaliando a prevalência de sinais e sintomas, bem como características fisiopatológicas dessa entidade clínica. Foi revisado o prontuário de um paciente internado na enfermaria da Clínica Médica do Hospital Regional do Cariri (CE) no período de junho a julho de 2018. Além disso, foi realizada revisão de literatura em base de dados (PubMed®) direcionada ao tema proposto. O diagnóstico de mieloma múltiplo foi comprovado por mielograma, sendo prontamente iniciada a corticoterapia e avaliada a resposta clínica após essa terapêutica. Apesar de incomum e menos frequentemente relacionada ao mieloma múltiplo, a síndrome de hiperviscosidade está relacionada a uma grande taxa de mortalidade quando apresenta diagnóstico tardio. A terapia de primeira linha indicada para a síndrome de hiperviscosidade foi a plasmaferese, no entanto, as condições clínicas (instabilidade hemodinâmica) impossibilitaram sua realização. O desfecho deste caso foi o óbito do paciente. Concluiu-se que o diagnóstico precoce e a intervenção terapêutica estão diretamente relacionados à ocorrência de menor incidência de complicações relacionadas ao mieloma múltiplo e à síndrome de hiperviscosidade.


Multiple myeloma is a progressive and incurable B-cell neoplasm characterized by unregulated and clonal proliferation of plasmocytes in the bone marrow. Hyperviscosity syndrome is one of the complications related to monoclonal gammopathies and is considered an oncological emergency. The aim of this study was to describe the clinical condition of a patient diagnosed with multiple myeloma who presented hyperviscosity syndrome, evaluating the prevalence of symptoms and signs, as well as the pathophysiological characteristics of this clinical entity. The medical records of a patient admitted to the Internal Medicine ward of the Hospital Regional do Cariri (CE) from June to July of 2018 were reviewed. In addition, we conducted a literature review in a database (PubMed®) directed to the theme proposed. The diagnosis of multiple myeloma was confirmed by myelogram, and corticosteroid therapy was promptly initiated and the clinical response was evaluated after this therapy. Although uncommon and less frequently related to multiple myeoloma, hyperviscosity syndrome is related to a high mortality rate when diagnosed late. The first line therapy indicated to hyperviscosity syndrome was plasmapheresis; however, the clinical conditions (hemodynamic instability) precluded its performance. The outcome of this case was the patient's death. Thus, it was concluded that early diagnosis and therapeutic intervention are directly related to the occurrence of lower incidence of complications related to multiple myeloma and hyperviscosity syndrome.


Subject(s)
Humans , Male , Middle Aged , Blood Viscosity , Melena/etiology , Neoplasms, Plasma Cell/complications , Hypergammaglobulinemia/etiology , Multiple Myeloma/complications , Palliative Care , Blood Protein Electrophoresis , gamma-Globulins/analysis , Dexamethasone/therapeutic use , Myelography , Radiography , Cardiovascular Agents/therapeutic use , beta 2-Microglobulin/analysis , Adrenal Cortex Hormones/therapeutic use , Fatal Outcome , Hypergammaglobulinemia/diagnosis , Intestinal Obstruction/etiology , Intestinal Perforation/etiology , Intestines/blood supply , Ischemia/surgery , Ischemia/complications , Multiple Myeloma/drug therapy , Multiple Myeloma/blood , Multiple Myeloma/diagnostic imaging
4.
Rev. cuba. reumatol ; 22(supl.1): e853, graf
Article in Spanish | LILACS, CUMED | ID: biblio-1280391

ABSTRACT

Introducción: El lupus eritematoso sistémico es el modelo clásico de enfermedad autoinmune. En el desarrollo de la enfermedad intervienen varios tipos de inmunoglobulinas, con predominio de la IgG, IgM e IgA. Objetivo: Describir la utilidad del cociente albúmina/globulina como un indicador de actividad en el lupus eritematoso sistémico. Desarrollo: Se estima que el 50 por ciento de los pacientes con lupus eritematoso sistémico muestran una hipoalbuminemia con una hipergammaglobulinemia. La hipoalbuminemia en mayor medida está relacionada con la presencia de nefritis lúpica. La mitad de los pacientes con nefritis lúpica presentan proteinuria en el orden del síndrome nefrótico. Esta proteinuria iguala o invierte parcialmente el valor del cociente albúmina/globulina. El cociente albúmina/globulina invertido por sí solo es insuficiente para afirmar la presencia de actividad en el lupus eritematoso sistémico. Se deben excluir otras entidades clínicas causantes de hipergammaglobulinemia policlonal. Los criterios de actividad del lupus eritematoso sistémico incrementan la sensibilidad del cociente albúmina/globulina invertido. Conclusiones: La interpretación del cociente albúmina/globulina debe ir aparejada a la estimación de actividad por los criterios clínicos de mayor uso (SLICC, SLEDAI, BILAG). No en todos los pacientes con lupus eritematoso sistémico puede interpretarse como criterio de actividad, por lo que es necesario excluir otras entidades clínicas(AU)


Introduction: Systemic lupus erythematosus is the model of autoimmune disease. Several types of immunoglobulins are involved in the development of the disease, mainly IgG, IgM and IgA. Objective: To describe the potential use of the albumin/globulin ratio as an indicator of activity in systemic lupus erythematosus. Development: fifty percent of patients with systemic lupus erythematosus exhibit hypoalbuminemia with hypergammaglobulinemia. Hypoalbuminemia is mainly related to the presence of lupus nephritis. The half of patients with lupus nephritis develops proteinuria with values of nephrotic syndrome. The proteinuria equals or partially reverses the albumin/globulin ratio. The inverted albumin/globulin ratio is insufficient to establish the presence of lupus activity. Other clinical entities producing polyclonal hypergammaglobulinaemia should be excluded. The systemic lupus erythematosus activity criteria increase the sensitivity of the inverted albumin/globulin ratio. Conclusions: The interpretation of the albumin/globulin ratio requires the activity estimation by different clinical criteria (SLICC, SLEDAI, BILAG). The inverted albumin/globulin ratio cannot be interpreted as a stand-alone indicator of disease activity in every systemic lupus erythematosus patients(AU)


Subject(s)
Humans , Proteinuria , Autoimmune Diseases , Immunoglobulin A/analysis , Immunoglobulin G/analysis , Immunoglobulin M/analysis , Hypoalbuminemia , Hypergammaglobulinemia/diagnosis , Lupus Erythematosus, Systemic/diagnosis , Nephrotic Syndrome , Odds Ratio , Albumins/analysis
5.
Immune Network ; : e26-2019.
Article in English | WPRIM | ID: wpr-764020

ABSTRACT

Since primary Sjögren's syndrome (pSS) is an autoummune disease of B cell hyperactivity and pathologic autoantibody response, follicular helper T (Tfh) cells and follicular regulatory T (Tfr) cells are suggested to be key players in pSS. We examined subsets of Tfh and Tfr cells from the blood in pSS patients, and whether these subsets represent disease activity, glandular inflammation, or autoantibody responses in pSS. Circulating Tfh and Tfr cells, along with their specific subsets, were identified from the peripheral blood of 18 pSS patients and 14 age- and sex-matched healthy controls (HCs) using flow cytometry analysis. Blood Tfr and Tfh cell ratios were increased in pSS patients compared with HCs. The CCR7(lo)PD-1(hi) subset of circulating Tfh cells was increased in pSS patients with high degree of focal lymphocytic sialadenitis; whereas circulating Tfh cells did not differ between pSS patients and HCs. The frequency of CCR7(lo)PD-1(hi) Tfh cells was significantly correlated with disease activity scores and differentiated B cells. PD-1 expression on blood Tfh and Tfr cells showed positive correlations with IL-21 in pSS. Increasing trend of blood Tfr cells was observed in pSS patients, and blood Tfr cells (particularly Th1 and Th17 subsets) represented hypergammaglobulinemia in pSS. In summary, circulating CCR7(lo)PD-1(hi) Tfh cells indicated disease activity and glandular inflammation in pSS. Circulating Tfr cells, shifted toward Th1 and Th17 subsets, indicated ongoing IgG production in pSS. Subsets of circulating Tfh or Tfr cells could be biomarkers for disease monitoring and patient stratification in pSS.


Subject(s)
Humans , Autoantibodies , B-Lymphocytes , Biomarkers , Flow Cytometry , Hypergammaglobulinemia , Immunoglobulin G , Inflammation , Sialadenitis , T-Lymphocyte Subsets , T-Lymphocytes , T-Lymphocytes, Helper-Inducer , T-Lymphocytes, Regulatory
6.
Arch. argent. pediatr ; 116(2): 331-335, abr. 2018. ilus, tab
Article in Spanish | LILACS, BINACIS | ID: biblio-887481

ABSTRACT

El síndrome de Goldbloom es una rara entidad clínica de etiología desconocida que ocurre casi exclusivamente en pediatría. Consiste en un síndrome febril prolongado con hiperostosis perióstica y disproteinemia, que, con frecuencia, simula una patología hematooncológica o linfoproliferativa. El diagnóstico se hace por exclusión de las diferentes causas de dolor de los huesos y se asocia a hipergammaglobulinemia, hipoalbuminemia, eritrosedimentación acelerada e imágenes radiológicas de periostitis. La sintomatología, la radiología y los parámetros de laboratorio remiten en un tiempo variable, que va, habitualmente, de los 3 a los 12 meses. Se presenta a un paciente de 6 años con dolores óseos difusos, hiperostosis perióstica, síndrome febril prolongado de 8 meses de evolución, pérdida de peso y reactantes de fase aguda elevados con disproteinemia (hipergammaglobulinemia e hipoalbuminemia). Debe considerarse el síndrome de Goldbloom en un paciente con las manifestaciones descritas luego de la exclusión de la patología infecciosa, hematooncológica e inflamatoria de otra causa.


Goldbloom syndrome is a rare clinical entity, of unknown etiology that happens almost exclusively in pediatric population. It is a prolonged febrile syndrome with periosteal hyperostosis and dysproteinemia, and often simulates an hematooncology or lymphoproliferative disease. The diagnosis is to rule out the different causes of bone pain associated with hypergammaglobulinemia, hypoalbuminemia, high erythrocyte sedimentation rate and periostitis at the radiographies. Symptomatology, radiology and laboratory parameters refer in a variable time, usually from 3 to 12 months. We report the case of a six-year-old boy with diffuse bone pain, prolonged febrile syndrome (of 8 months of evolution), weight loss and elevated acute phase reactants with dysproteinemia (hypergammaglobulinemia and hypoalbuminemia). Goldbloom syndrome should be considered in patients with prolonged febrile syndrome and cortical hyperostosis after the exclusion of infectious, lymphoproliferative or inflammatory disease.


Subject(s)
Humans , Male , Child , Hyperostosis/diagnosis , Fever/diagnosis , Hypergammaglobulinemia/diagnosis , Syndrome , Hypoalbuminemia/diagnosis , Diagnosis, Differential
7.
Acta bioquím. clín. latinoam ; 51(2): 213-220, jun. 2017. ilus, graf, tab
Article in Spanish | LILACS | ID: biblio-886114

ABSTRACT

El proteinograma por electroforesis (PxE) sérico es solicitado para detectar modificaciones del perfil proteico. El objetivo del trabajo fue evaluar las alteraciones de la zona gammaglobulina y su correspondencia con distintos estados clínico-patológicos. Se incluyeron 7.259 pacientes (1-89 años) a los que en 2013 se les solicitó PxE. Según el trazado densitométrico, en la zona gammaglobulina se reconocieron diferentes grupos: hipogammaglobulinemia (<0,60 g/dL), hipergammaglobulinemia policlonal (≥1,80 g/dL), banda monoclonal (BM) y bandas oligoclonales. Prevaleció la hipergammaglobulinemia policlonal (4,2%), seguida por BM (1,4%) e hipogammaglobulinemia (0,8%). Hipergammaglobulinemia policlonal (>3 g/dL) se observó en: hepatitis autoinmune, cirrosis, síndrome de Sjögren, enfermedad mixta del tejido conectivo, HIV, hepatitis C y enfermedad de Castleman. El hallazgo de BM correspondió a 47% de pacientes con gammapatía monoclonal de significado incierto y 40% con mieloma múltiple; el 0,5% fueron casos nuevos. Con hipogammaglobulinemias, en adultos prevaleció la inmunosupresión terapéutica (55%), seguida por diabetes/síndrome metabólico/hipotiroidismo (23%); en niños, 22% por inmunosupresión y 78% con hipogammaglobulinemia no clasificada como inmunodeficiencia primaria. Se concluye que en 6,4% de los PxE se observó alteración de la zona gammaglobulina; prevaleció la hipergammaglobulinemia policlonal. En 1 de cada 200 PxE se pesquisó un paciente con BM. El hallazgo de hipergammaglobulinemia policlonal o BM se correspondió con distintos estados clínico-patológicos.


Serum protein electrophoresis (PEP) is requested to screen changes in the protein profile. The aim of this study was to evaluate alterations in the gamma globulin zone and correspondence with various clinical and pathological states. 7259 patients were included (1-89 years of age) who had been requested a PEP in 2013. According to the densitometric tracing, in the gamma globulin zone different groups were recognized: hypogammaglobulinemia (<0.60 g/dL), polyclonal hypergammaglobulinemia (≥1,80 g/dL), monoclonal band (MB) and oligoclonal band. The polyclonal hypergammaglobulinemia prevailed (4.2%), followed by MB (1.4%) and hypogammaglobulinemia (0.8%). Polyclonal hypergammaglobulinemia (>3 g/dL) was observed in autoimmune hepatitis, alcoholic cirrhosis, Sjögren's syndrome, mixed connective tissue disease, HIV, hepatitis C and Castleman's disease. The MB finding corresponded to a 47% of patients with monoclonal gammopathy of undetermined significance and 40% with multiple myeloma; 0.5% were new cases. In adults, hipogammaglobulinemias prevailed in therapeutic immunosuppression cases (55%), followed by patients with diabetes/ metabolic syndrome/ hypothyroidism (23%); in children, 22% with immunosuppression and 78% corresponded to hipogammaglobulinemias not classified as primary immunodeficiency. To conclude, an alteration in the gamma globulin zone was observed in 6.4% of PEP. In 1 out of 200 PEP MB was found. The finding of polyclonal hypergammaglobulinemia or MB corresponded to different clinicopathological states.


O proteinograma por eletroforese (PXE) sérico é solicitado para detectar modificações no perfil proteíco. O objetivo do trabalho foi avaliar as alterações da área gammaglobulina e sua correspondência com diversos estados clínico-patológicos. Incluíram-se 7259 pacientes (1-89 anos) aos quais, em 2013, foi solicitado um PxE. De acordo com o traçado densitométrico, na área gammaglobulina, diferente grupos foram reconhecidos: hipogammaglobulinemia (<0,60 g/dL), hipergammaglobulinemia policlonal (≥1,80 g/dL), banda monoclonal (BM) e bandas oligoclonais. Prevaleceu a hipergammaglobulinemia policlonal (4,2%), seguida por BM (1,4%) e hipogammaglobulinemia (0,8%). Hipergammaglobulinemia policlonal (>3 g/dL) foi observada em: Hepatite autoimune, cirrose, síndrome de Sjögren, doença mista do tecido conjuntivo, HIV, hepatite C e doença de Castleman. O achado de BM correspondeu a 47% de pacientes com gammapatia monoclonal de significado indeterminado e 40% com mieloma múltiplo; 0,5% eram casos novos. Com hipogammaglobulinemias em adultos prevaleceu a imunossupressão terapêutica (55%), seguida por diabete/síndrome metabólica/hipotireoidismo (23%); em crianças, 22% por imunossupressão e 78% com hipogammaglobulinemia não classificados como imunodeficiência primária. Conclui-se que em 6,4% dos PxE foi observada alteração da área gammaglobulina; prevaleceu a hipergammaglobulinemia policlonal. Em 1 de cada 200 PxE foi encontrado um paciente com BM. O achado de hipergammaglobulinemia policlonal ou BM se correspondeu com diferentes estados clínico-patológicos.


Subject(s)
Humans , Infant , Child, Preschool , Child , Adolescent , Adult , Middle Aged , Aged , Aged, 80 and over , gamma-Globulins/analysis , Electrophoresis/methods , gamma-Globulins , Electrophoresis, Agar Gel , Hypergammaglobulinemia/pathology
8.
Arq. Asma, Alerg. Imunol ; 1(2): 226-230, abr.jun.2017. ilus
Article in Portuguese | LILACS | ID: biblio-1380430

ABSTRACT

A doença sistêmica relacionada à IgG4 é uma doença emergente, recentemente descrita, caracterizada clinicamente por aumento parcial ou total de um órgão, e, por isso, com amplo espectro de manifestações clínicas. Esta é uma doença sistêmica fibroinflamatória, patologicamente provocada pela infiltração de plasmoblastos IgG4 positivos que levam à inflamação eosinofílica do tecido e, consequentemente, fibrose estoriforme. Quando o diagnóstico é precoce, a melhora clínica e resposta sustentada com corticosteroides sistêmicos é impressionante. O diagnóstico é baseado em critérios patológicos, mas, recentemente, alguns trabalhos têm descrito que plasmoblastos no soro podem servir como um fator independente para auxiliar no diagnóstico da doença. Este artigo descreve uma apresentação atípica da doença relacionada à IgG4, em um paciente linfopênico com medição inconclusiva de plasmoblastos no soro.


IgG4-related systemic disease is a recently described, emerging condition, clinically characterized by partial or total enlargement of an organ, with a broad spectrum of clinical manifestations. It is a systemic fibroinflammatory condition caused by the infiltration of IgG4-positive plasmablasts that lead to eosinophilic inflammation of tissues and consequently storiform fibrosis. When diagnosis is early, clinical improvement and maintained response achieved with systemic corticosteroids is impressive. Diagnosis is based on pathological criteria, but recent papers have described that serum plasmablasts may serve as an independent factor to aid in diagnosis. This paper describes an atypical presentation of IgG4-related disease in a lymphopenic patient with inconclusive serum plasmablast measurement.


Subject(s)
Humans , Female , Middle Aged , Immunoglobulin G4-Related Disease , Immunoglobulin G4-Related Disease/diagnosis , Lymphopenia , Serositis , Eosinophils , Hypergammaglobulinemia
9.
Clinics ; 71(2): 73-77, Feb. 2016. tab, graf
Article in English | LILACS | ID: lil-774530

ABSTRACT

OBJECTIVES: This study was conducted to clarify the rate of late diagnosis of HIV infection and to identify relationships between the reasons for HIV testing and a late diagnosis. METHODS: This retrospective cohort study was conducted among HIV-positive patients at the Jikei University Hospital between 2001 and 2014. Patient characteristics from medical records, including age, sex, sexuality, the reason for HIV testing and the number of CD4-positive lymphocytes at HIV diagnosis, were assessed. RESULTS: A total of 459 patients (men, n=437; 95.2%) were included in this study and the median age at HIV diagnosis was 36 years (range, 18-71 years). Late (CD4 cell count <350/mm3) and very late (CD4 cell count <200/mm3) diagnoses were observed in 61.4% (282/459) and 36.6% (168/459) of patients, respectively. The most common reason for HIV diagnosis was voluntary testing (38.6%, 177/459 patients), followed by AIDS-defining illness (18.3%, 84/459 patients). Multivariate analysis revealed a significant association of voluntary HIV testing with non-late and non-very-late diagnoses and there was a high proportion of AIDS-defining illness in the late and very late diagnosis groups compared with other groups. Men who have sex with men was a relative factor for non-late diagnosis, whereas nonspecific abnormal blood test results, such as hypergammaglobulinemia and thrombocytopenia, were risk factors for very late diagnosis. CONCLUSIONS: Voluntary HIV testing should be encouraged and physicians should screen all patients who have symptoms or signs and particularly hypergammaglobulinemia and thrombocytopenia, that may nonspecifically indicate HIV infection.


Subject(s)
Adolescent , Adult , Aged , Female , Humans , Male , Middle Aged , Young Adult , Delayed Diagnosis , Health Behavior , HIV Infections/diagnosis , Hypergammaglobulinemia/blood , Cohort Studies , HIV Infections/complications , Hospitals, University , Japan , Mass Screening/standards , Pneumonia, Pneumocystis/complications , Retrospective Studies , Thrombocytopenia/blood
10.
Annals of Dermatology ; : 759-762, 2015.
Article in English | WPRIM | ID: wpr-164326

ABSTRACT

Cutaneous and systemic plasmacytosis (CSP) is a rare disorder of unknown etiology characterized by cutaneous polyclonal plasma cell infiltrates associated with various extracutaneous involvement and polyclonal hypergammaglobulinemia. Here, we report on a 54-year-old male patient with chronic renal insufficiency who presented with disseminated reddish-brown macules and plaques on the face and trunk. In our evaluation, he was found to have lymphadenopathy, polyclonal hypergammaglobulinemia; benign plasma cell infiltration involving the skin, bone marrow, and retroperitoneal area; and renal amyloidosis. To the best of our knowledge, this is the first reported case of CSP associated with renal amyloidosis.


Subject(s)
Humans , Male , Middle Aged , Amyloidosis , Bone Marrow , Hypergammaglobulinemia , Lymphatic Diseases , Plasma Cells , Renal Insufficiency, Chronic , Skin
11.
Bol. Asoc. Argent. Odontol. Niños ; 43(1): 19-27, abr.-ago. 2014. ilus, tab, graf
Article in Spanish | LILACS | ID: lil-761839

ABSTRACT

El síndrome de Hiper EgE (SHIE) es una rara inmunodeficiencia caracterizada por abscesos cutáneos, neumonías recurrentes, conformación de neumatoceles y elevados niveles de IgE en suero. Se ha reconocido la asociación de rasgos faciales, esqueléticos y dentales, pero su frecuencia es poco conocida. Objetivo: describir la epidemiología, presentación clínica, hallazgos de laboratorio y tratamiento de este síndrome desde el punto de vista médico y odontológico, con énfasis en las manifestaciones estomatológicas y dentales. Métodos. Métodos: realizamos una revisión científica sistemática de todos los reporte y series de casos de SHIE en las bases de datos Lilacs, Medline, SciELO y Biblioteca Cochrane, utilizando como descriptores DeCS/MeSH las palabras claves: hyper IgE AND immunodeficiency, hypereosinophilia, Job´s syndrome, hiperinmunoglobulinemia E. Resultados: revisamos 31 publicaciones con 328 pacientes. Los abscesos cutáneos se encontraron en 89 pior ciento de los casos, la neumonía en el 87 por ciento y la IgE sérica dio una mediana de 3.417 Ul/mL. Los rasgos faciales característicos estuvieron en el 69 por ciento, las alteraciones dentarias en 58 por ciento y la candidiasis oral fue reportada en 53 por ciento de los pacientes. Conclusión: el síndrome de IgE es un desorden multisistémico que afecta a la dentición, el esqueleto, el tejido conectivo y el sistema inmune. Por esto, el odontopediatra debe ser capaz de reconocer el fenotipo orofacial para mejorar la calidad del diagnóstico y brindar el abordaje terapéutico apropiado...


Subject(s)
Humans , Male , Female , Hypergammaglobulinemia/complications , Immunoglobulin E , Oral Manifestations , Tooth Abnormalities/etiology , Hypergammaglobulinemia/epidemiology , Hypergammaglobulinemia/therapy , Data Interpretation, Statistical , Job Syndrome/pathology , Hypergammaglobulinemia/blood
12.
J. bras. med ; 102(1)jan.-fev. 2014. tab
Article in Portuguese | LILACS | ID: lil-712209

ABSTRACT

Pancreatite autoimune é uma entidade caracterizada por processo inflamatório autoimune, no qual há proeminente infiltrado linfocitário associado à fibrose do pâncreas, com disfunção orgânica. Nas últimas quatro décadas, várias descrições morfológicas foram propostas para caracterizar a doença. Recentemente, o termo pancreatite autoimune se tornou largamente aceito, embora, aparentemente, a pancreatite autoimune seja uma doença heterogênea.


Autoimmune pancreatitis is a entity characterized by an autoimmune inflammatory process where there is an outstanding lymphocytic infiltrated associated with fibrosis of pancreas with organic dysfunction. The last four decades, many morphological descriptions have been proposed in order to characterized the disease. Recently, autoimmune pancreatitis term became widely accepted, however, autoimmune pancreatitis is a heterogeneous disease.


Subject(s)
Humans , Male , Female , Autoimmune Diseases/diagnosis , Pancreatitis/diagnosis , Pancreatitis/therapy , Abdominal Pain/drug therapy , Back Pain/drug therapy , Steroids/administration & dosage , Steroids/therapeutic use , Hypergammaglobulinemia , Jaundice, Obstructive/drug therapy , Immunoglobulin G/blood , Pancreas/pathology
13.
Allergy, Asthma & Immunology Research ; : 366-369, 2014.
Article in English | WPRIM | ID: wpr-132492

ABSTRACT

Chronic granulomatous disease (CGD) is a rare immunodeficiency disease, which is characterized by the lack of a functional nicotinamide adenine dinucleotide phosphate (NADPH) oxidase in phagocytes. The disease presents leukocytosis, anemia, hypergammaglobulinemia, and granuloma formation of the skin, lung, or lymph nodes. The mutation of the CYBB gene encoding gp91phox, located on chromosome Xp21.1 is one of the causes of CGD. We report a patient with X-linked CGD who carried a novel mutation, a c.1133A>G (paAsp378Gly) missense mutation, in the CYBB gene.


Subject(s)
Humans , Anemia , Granuloma , Granulomatous Disease, Chronic , Hypergammaglobulinemia , Leukocytosis , Lung , Lymph Nodes , Mutation, Missense , NADP , Oxidoreductases , Phagocytes , Skin
14.
Allergy, Asthma & Immunology Research ; : 366-369, 2014.
Article in English | WPRIM | ID: wpr-132489

ABSTRACT

Chronic granulomatous disease (CGD) is a rare immunodeficiency disease, which is characterized by the lack of a functional nicotinamide adenine dinucleotide phosphate (NADPH) oxidase in phagocytes. The disease presents leukocytosis, anemia, hypergammaglobulinemia, and granuloma formation of the skin, lung, or lymph nodes. The mutation of the CYBB gene encoding gp91phox, located on chromosome Xp21.1 is one of the causes of CGD. We report a patient with X-linked CGD who carried a novel mutation, a c.1133A>G (paAsp378Gly) missense mutation, in the CYBB gene.


Subject(s)
Humans , Anemia , Granuloma , Granulomatous Disease, Chronic , Hypergammaglobulinemia , Leukocytosis , Lung , Lymph Nodes , Mutation, Missense , NADP , Oxidoreductases , Phagocytes , Skin
15.
Journal of Biomedical Research ; : 96-99, 2014.
Article in English | WPRIM | ID: wpr-163006

ABSTRACT

A 7-year-old, spayed female, domestic short hair cat showed signs of a 2-week history of chronic anorexia, depression, and severe weight loss. Upon physical examination, pyrexia, mild gingivitis, and pale mucus membranes were noted. Laboratory analysis revealed normocytic normochromic non-regenerative anemia, severe thrombocytopenia, and hypergammaglobulinemia. Serum protein electrophoresis revealed the presence of elevated alpha-2 fraction within the globulin concentration. Based on history, clinical signs, and laboratory results, systemic viral infection was strongly suspected. Reverse transcriptase polymerase chain reaction identified the presence of feline immunodeficiency virus (FIV) in the serum. Furthermore, gene sequencing revealed the virus as FIV subtype A. Treatment with anti-retroviral agents, including azidothymidine (AZT) and recombinant human interferon-alpha, was continued for 4 weeks. However, the patient's clinical condition deteriorated, resulting in death 1 month after initiation of treatment due to progressive renal failure. Necropsy and histopathology revealed hepatic and renal necrosis with hyper-cellular bone marrow mainly comprised of myeloid precursor cells. This case report is the first to describe phylogenetic subtyping, anti-retroviral combination treatment, and clinical outcomes in an FIV-infected cat in Korea. In addition, this report suggests that treatment should be initiated during the early phase of infection that could be effective for the virus.


Subject(s)
Animals , Cats , Child , Female , Humans , Anemia , Anorexia , Anti-Retroviral Agents , Bone Marrow , Depression , Electrophoresis , Fever , Gingivitis , Hair , Hypergammaglobulinemia , Immunodeficiency Virus, Feline , Interferon-alpha , Korea , Membranes , Mucus , Necrosis , Physical Examination , Renal Insufficiency , Reverse Transcriptase Polymerase Chain Reaction , Thrombocytopenia , Weight Loss , Zidovudine
16.
Korean Journal of Dermatology ; : 465-469, 2013.
Article in Korean | WPRIM | ID: wpr-186528

ABSTRACT

Rosai-Dorfman disease (RDD) or sinus histiocytosis with massive lymphadenopathy (SMHL) is a benign histiocytic proliferative disorder of unknown etiology. The disease is usually accompanied by massive bilateral lymphadenopathy, fever, elevated erythrocyte sedimentation rate, leukocytosis with neutrophilia, and polyclonal hypergammaglobulinemia. Histopathologic examinations showed characteristically large histiocytes exhibiting emperipolesis. On immunohistochemical stains, histiocytes are positive for CD68 and S-100 protein, but negative for CD1a. The lymph node involvement is typical, but it may also involve other systemic organs in one third of the cases such as skin, upper respiratory tract, bones and so on. Patients with purely cutaneous Rosai-Dorfman diseases are of older age at onset of the disease with a reversed male/female ratio, thus, cutaneous Rosai-Dorfman disease is recognized as a distinct entity from the Rosai-Dorfman disease. Herein, we present a 50-year-old man with erythematous papules and indurated plaques on both cheeks, diagnosed as cutaneous Rosai-Dorfman disease. The lesions were treated with isotretinoin 10 mg bid for 9 months with pulsed dye laser.


Subject(s)
Humans , Blood Sedimentation , Cheek , Coloring Agents , Emperipolesis , Fever , Histiocytes , Histiocytosis, Sinus , Hypergammaglobulinemia , Isotretinoin , Lasers, Dye , Leukocytosis , Lymph Nodes , Lymphatic Diseases , Respiratory System , S100 Proteins , Skin
17.
GEN ; 66(4): 237-243, dic. 2012. ilus, graf, mapas, tab
Article in Spanish | LILACS | ID: lil-676450

ABSTRACT

Introducción: La Hepatitis Autoinmune (HAI) es una hepatopatía inflamatoria crónica y progresiva, de etiología desconocida, con presencia de autoanticuerpos circulantes e hipergammaglobulinemia. La mayoría de los pacientes responden adecuadamente al tratamiento inmunosupresor, pero si no se instaura se produce destrucción progresiva del parénquima hepático evolucionando a cirrosis e insuficiencia hepática. La interrupción temprana de la terapia puede causar recaídas y aumentar el riesgo de progresión a cirrosis.Objetivo: evaluar la evolución y la respuesta al tratamiento de los pacientes pediátricos con HAI. Materiales y métodos: estudio descriptivo, retrospectivo y transversal de 51 pacientes atendidos en el servicio de Gastroenterología Pediátrica del Hospital JM de los Ríos, de abril de 1996 a septiembre de 2010. De 51 pacientes con diagnóstico de HAI se incluyeron 48 pacientes con más de un año de tratamiento para evaluar evolución y respuesta.Resultados: 79, % de los pacientes presentaron remisión a los 20,4 ± 13,8 meses, 25 % tuvo recaídas. 10/48 (20,8 %) mostraron respuesta incompleta y 38,5 % de ellos no tuvo adherencia al tratamiento (p=0,001). 33/48 (68,8 %) presentaron complicaciones, siendo las más frecuentes: 64,6 % hipertensión portal, 27,2 % osteosporosis/osteopenia y 18,8 % evolucionaron a cirrosis hepática.3 (8,5 %) pacientes presentaron remisión con biopsia hepática normal, luego de aproximadamente 7 años, por lo que se les suspendió el tratamiento, manteniéndose la remisión durante 3,5 años de seguimiento. Dos pacientes requirieron trasplante hepático.Conclusiones: La mayoría de los pacientes respondieron adecuadamente al tratamiento inmunosupresor. La cuarta parte sufrió recaídas. La respuesta incompleta se relacionó significativamente con la falta de adherencia al tratamiento.


Introduction: Autoimmune hepatitis (AIH) is a progressive, chronic disease of unknown etiology, characterized for the presence of circulating autoantibodies and hyper gammaglobulinemia. Most patients respond to immunosuppressive treatment, otherwise, liver parenchimal is progressively destroyed leading to cirrhosis and liver failure. Early withdrawal of therapy might cause relapses and increased risk to cirrhosis.Objective: To assess HAI outcome and treatment response in pediatric patients.Methods: By a retrospective and descriptive analysis we evaluated 51 patients who attended the Pediatric Gastroenterology Department at the “J.M de Los Rios” Children Hospital from April 1996 to September 2010. 48 of these 51 patients have been on immunosuppressive treatment for more than one year.Results: 79.2 % of patients experienced remission at 20.4 ± 13.8 months, 25 % relapsed. 10/48 (20.8 %) showed incomplete response and 38.5 % had no adherence to treatment (p = 0.001). 33/48 (68.8 %) had complications, being the most frequent portal hypertension 64.6 %, following by osteoporosis and osteopenia 27,2 %, and 18.8 % developed cirrhosis.3 (8.5 %) patients had remission with normal liver biopsy after approximately 7 years, so treatment was discontinued, maintaining remission for 3.5 years. Two patients required liver transplantation.Conclusions: Most patients responded well to immunosuppressive therapy. 25 % suffered relapses. The incomplete response was significantly associated to non-adherence to treatment.


Subject(s)
Humans , Male , Female , Child , Hepatitis, Autoimmune/diagnosis , Hepatitis, Autoimmune/etiology , Hepatitis, Autoimmune/drug therapy , Liver Diseases/diagnosis , Transaminases/adverse effects , Transaminases/metabolism , Adrenal Cortex Hormones/therapeutic use , Gastroenterology , Hypergammaglobulinemia
18.
Chinese Journal of Stomatology ; (12): 208-213, 2012.
Article in Chinese | WPRIM | ID: wpr-281629

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the clinical and laboratory characteristics of tumor like Sjögren's syndrome (TLSS) patients and non-tumor like Sjögren's syndrome (NTLSS) and the incidence of lymphoma in patients of Sjögren's syndrome (SS).</p><p><b>METHODS</b>A retrospective analysis was carried out in 199 primary SS (including TLSS) patients who were recruited in Peking University School and Hospital of Stomatology from 1998 to 2010. Clinical and laboratory information were collected. The patients were divided into two groups: TLSS (n = 25) and NTLSS (n = 174). Clinical and laboratory characteristics were compared between these two groups by a statistical analysis.</p><p><b>RESULTS</b>Of the 25 TLSS patients, 23 had enlargements of parotid glands and 2 had enlargements of submandibular glands. There were significant differences of salivary scintigraphy appearance (P = 0.018), hypergammaglobulinemia (P = 0.014), rheumatoid factor positive rate (P = 0.001), formation of the ectopic germinal centers (P = 0.014), double positive rate of anti-SSA antibody and anti-SSB antibody (P < 0.001) between the TLSS and NTLSS patients. Among the 25 TLSS patients, 3 developed lymphomas, accounting for 1.5% (3/199) of the total 199 patients and 12% (3/25) of the TLSS patients. Lymphoma subtypes included one diffused large B-cell lymphoma and two mucosa-associated lymphoid tissue lymphoma. There was no lymphoma detected in NTLSS patients.</p><p><b>CONCLUSIONS</b>There are clinical and laboratory differences between TLSS and NTLSS patients, with a more tendency to develop lymphomas in TLSS patients.</p>


Subject(s)
Adult , Female , Humans , Male , Middle Aged , Antibodies, Antinuclear , Metabolism , Hypergammaglobulinemia , Metabolism , Lymphoma, B-Cell, Marginal Zone , Diagnostic Imaging , Metabolism , Pathology , Lymphoma, Large B-Cell, Diffuse , Diagnostic Imaging , Metabolism , Pathology , Parotid Gland , Pathology , Radionuclide Imaging , Retrospective Studies , Rheumatoid Factor , Metabolism , Salivary Glands , Diagnostic Imaging , Sjogren's Syndrome , Diagnostic Imaging , Metabolism , Pathology , Submandibular Gland , Pathology
19.
Medisan ; 15(12)dic. 2011.
Article in Spanish | LILACS | ID: lil-616431

ABSTRACT

Se expone el caso clínico de una paciente de 50 años de edad, que presentó síntomas sistémicos muy variables: queratoconjuntivitis seca, caída de la cola de la ceja, ambivalencia afectiva, hipotermia e intolerancia al frío, así como sequedad de las mucosas oculares, la boca (aun durante las comidas) y la piel, además de polimialgias y poliartralgias, por lo cual ingresó en el Hospital Municipal Ezequiel Miranda, perteneciente al municipio de Julio Antonio Mella (Santiago de Cuba). Los resultados de los exámenes complementarios condujeron al diagnóstico del síndrome de Sjõgren y se aplicó tratamiento con esteroides e inmunosupresores. La paciente mejoró y egresó de la institución hospitalaria, con la indicación de seguimiento ambulatorio especializado.


The case of a 50 year-old patient is reported with highly variable systemic symptoms: keratoconjunctivitis sicca, drop of the eyebrow tail, emotional ambivalence, hypothermia and cold intolerance, as well as dryness of ocular mucosa, mouth (even during meals) and skin, polymyialgia and polyarthralgia, reason why she was admitted to Ezequiel Miranda Municipal Hospital, belonging to Julio Antonio Mella municipality (Santiago de Cuba). The complementary test results led to the diagnosis of the Sjõgren's syndrome and treatment was based on steroids and immunosuppressants. The patient improved and was discharged from the hospital institution with indication of specialized outpatient follow-up.


Subject(s)
Humans , Female , Steroids/therapeutic use , Hypergammaglobulinemia , Immunosuppressive Agents/therapeutic use , Secondary Care , Sjogren's Syndrome/therapy
20.
Korean Journal of Pathology ; : 632-638, 2011.
Article in English | WPRIM | ID: wpr-107776

ABSTRACT

Systemic plasmacytosis is an uncommon disorder characterized by widely disseminated macular skin eruptions composed of polyclonal lymphoplasmacytic infiltrates associated with variable extracutaneous involvement. An aggressive clinical course has been observed in a small number of patients, but most cases have followed chronic and benign clinical course without spontaneous remission. Previously reported cases of this entity have been described almost exclusively in Japanese patients. We recently experienced a case of systemic plasmacytosis in a 48-year-old Korean female patient. Initial skin biopsy specimen revealed patchy perivascular and periadnexal infiltrates of mature plasma cells. Serum immunoelectrophoresis revealed polyclonal hypergammaglobulinemia, and polyclonal plasmacytosis was noted on the subsequent biopsy specimens of left supraclavicular and axillary lymph nodes. Multiple tiny pulmonary nodules appeared six years after the initial cutaneous presentation and were found to be of the same histologic appearance. We herein report a rare case of systemic plasmacytosis with a review of the literature.


Subject(s)
Female , Humans , Middle Aged , Asian People , Biopsy , Castleman Disease , Hypergammaglobulinemia , Immunoelectrophoresis , Interleukin-6 , Lymph Nodes , Plasma Cells , Remission, Spontaneous , Skin
SELECTION OF CITATIONS
SEARCH DETAIL